Funding
← Back to your selection

Longwood Fund

Activity from announced rounds

Activity in this selectionallina-health-258a8846
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$263M
3 disclosed · full round size, not this investor’s share

By stage

Series B3

By primary sector

Biotech3

By country

United States3

Rounds

3 in this selection
Khartis Therapeutics

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries B
Role not disclosed
Mediar Therapeutics

Develops therapies to halt fibrosis in multiple organ systems

$76MSeries B
Role not disclosed